fenadol 100mg modified-release tablets
proge farm s.r.l. baluardo la marmora, 4 - 28100 - novara, italy - diclofenac sodium - modified-release tablet - diclofenac sodium 100 mg - antiinflammatory and antirheumatic products
lodotra 1mg modified-release tablets
mundipharma corporation limited cambridge science park, milton road, cambridge, cb4 0ab, united kingdom - prednisone - modified-release tablet - prednisone 1 mg - corticosteroids for systemic use
lodotra 2mg modified-release tablets
mundipharma corporation limited cambridge science park, milton road, cambridge, cb4 0ab, united kingdom - prednisone - modified-release tablet - prednisone 2 mg - corticosteroids for systemic use
lodotra 5mg modified-release tablets
mundipharma corporation limited cambridge science park, milton road, cambridge, cb4 0ab, united kingdom - prednisone - modified-release tablet - prednisone 5 mg - corticosteroids for systemic use
natrixam 1.5mg/5mg modified-release tablets
les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - amlodipine, indapamide - modified-release tablet - indapamide 1.5 mg amlodipine 5 mg - calcium channel blockers
natrixam 1.5mg/10mg modified-release tablets
les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - amlodipine, indapamide - modified-release tablet - indapamide 1.5 mg amlodipine 10 mg - calcium channel blockers
omnic 0.4mg modified release capsules
astellas pharma europe b.v. - tamsulosin hydrochloride - modified-release capsule - tamsulosin hydrochloride 0.4 milligram(s) - urologicals
vastarel mr modified release film-coated tablet
les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - trimetazidine dihydrochloride - modified-release tablet - trimetazidine dihydrochloride 35 mg - cardiac therapy
vimovo 500mg/20mg modified-release tablets
astrazeneca uk limited 600, capability green, luton lu1 3lu, united kingdom - naproxen, esomeprazole - modified-release tablet - naproxen 500 mg esomeprazole 20 mg - antiinflammatory and antirheumatic products
klacid la 500mg modified release tablets
mylan ire healthcare limited - clarithromycin - modified-release tablet - 500 milligram(s) - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for treatment of infections caused by susceptible organisms. indications include: lower respiratory tract infections for example bronchitis and pneumonia. upper respiratory tract infections for example sinusitis and pharyngitis. skin and soft tissue infections for example folliculitis, cellulitis and erysipelas.